provenge what rubbish Talk that priority FDA approval will make phama's search for other like therapies is utter rubbish.
In the business world you don't wait until this timing. Positioning in cell therapies would have occurred years ago.
There has been no positioning in CVac and the reasoning is obvious. Biomira have not purchased a single stock. PHIIa trial results have been available to the world and anyone with deep pockets yet...
NO INTEREST
I wonder why ?
provenge what rubbish Talk that priority FDA approval will make...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.0¢ | $352.6K | 1.266M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 156231 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 2491 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |